Oral ingestion of water greatly elevates blood pressure in individuals with impaired autonomic reflexes. Whilethe effect averages 30-40 mmHg, there is large interindividual variation with occasional increases of 100mmHg. We were initially startled by the magnitude of this response, but others have now replicated it andconfirmed its magnitude. An effect is also found in treated hypertensive subjects and in normal subjects,albeit it at smaller magnitude. We have also found that ingestion of water potentiates the effect of the pressordrug phenylpropanolamine (PPA). In view of its magnitude and robustness, the pressor response to watermay signal an important but heretofore unrecognized mechanism at work in human cardiovascular regulationboth in health and disease. The water response may have important diagnostic and therapeutic implications.In particular, it may be the major unrecognized determinant of noise in blood pressure assessment in theolder population, and might possibly be a source of interindividual and intraindividual variation in orthostatictolerance.The purpose of this proposal is to address the mechanism of the cardiovascular effect of water ingestion,and address the basis of interindividual variation in this gastropressor response. We seek to understand ifthe sympathetic nervous system is mediating water's pressor response in Specific Aim 1.
In Specific Aim 2, we try to determine the macroscopic stimulus underlying the response.
In Specific Aims 3 and 4, we addresspotential efferent mechanisms at a more molecular level in both human subjects and in a mouse modelsystem. Finally in Specific Aim 5 we try to determine the basis of the age dependency of the pressorresponse to water.Although water is a part of daily life, we believe the gastropressor response we have observed may haveimportant consequences in health and disease.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Program Projects (P01)
Project #
2P01HL056693-11
Application #
7252842
Study Section
Heart, Lung, and Blood Initial Review Group (HLBP)
Project Start
2007-08-01
Project End
2012-04-30
Budget Start
2007-08-01
Budget End
2008-04-30
Support Year
11
Fiscal Year
2007
Total Cost
$318,583
Indirect Cost
Name
Vanderbilt University Medical Center
Department
Type
DUNS #
004413456
City
Nashville
State
TN
Country
United States
Zip Code
37212
Mar, Philip L; Raj, Satish R (2018) Orthostatic hypotension for the cardiologist. Curr Opin Cardiol 33:66-72
Chaugai, Sandip; Dickson, Alyson L; Shuey, Megan M et al. (2018) Co-Prescription of Strong CYP1A2 Inhibitors and the Risk of Tizanidine-Associated Hypotension: A Retrospective Cohort Study. Clin Pharmacol Ther :
van den Berg, Maarten P; Almomani, Rowida; Biaggioni, Italo et al. (2018) Mutations in CYB561 Causing a Novel Orthostatic Hypotension Syndrome. Circ Res 122:846-854
Mai, Tu H; Garland, Emily M; Diedrich, André et al. (2017) Hepatic and renal mechanisms underlying the osmopressor response. Auton Neurosci 203:58-66
Kawai, V K; Levinson, R T; Adefurin, A et al. (2017) A genetic risk score that includes common type 2 diabetes risk variants is associated with gestational diabetes. Clin Endocrinol (Oxf) 87:149-155
Pezawas, Thomas; Diedrich, André; Robertson, David et al. (2017) Risk of arrhythmic death in ischemic heart disease: a prospective, controlled, observer-blind risk stratification over 10 years. Eur J Clin Invest 47:231-240
Adefurin, A; Ghimire, L V; Kohli, U et al. (2017) Genetic variation in the alpha1B-adrenergic receptor and vascular response. Pharmacogenomics J 17:366-371
Kaufman, Melissa R; Chang-Kit, Laura; Raj, Satish R et al. (2017) Overactive bladder and autonomic dysfunction: Lower urinary tract symptoms in females with postural tachycardia syndrome. Neurourol Urodyn 36:610-613
Shaw, Brett H; Garland, Emily M; Black, Bonnie K et al. (2017) Optimal diagnostic thresholds for diagnosis of orthostatic hypotension with a 'sit-to-stand test'. J Hypertens 35:1019-1025
Kawai, Vivian K; Levinson, Rebecca T; Adefurin, Abiodun et al. (2017) Variation in the ?2A-adrenergic receptor gene and risk of gestational diabetes. Pharmacogenomics 18:1381-1386

Showing the most recent 10 out of 315 publications